Principia SGR

Total investments

52

Average round size

6M

Portfolio companies

41

Rounds per year

2.48

Lead investments

18

Follow on index

0.19

Exits

5

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryE-CommerceSoftwareMobileHealth CareMedical DeviceLife ScienceHardwareBiopharma

Summary

The company was established in Europe in Italy. The leading representative office of defined VC is situated in the Milan.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Principia SGR, startups are often financed by Atlante Seeds, Seventure Partners, Merifin Capital. The meaningful sponsors for the fund in investment in the same round are dPixel, Atlante Seeds, Antares Capital. In the next rounds fund is usually obtained by Merifin Capital, EASME - EU Executive Agency for SMEs, 360 Capital Partners.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Shopping. Among the most popular portfolio startups of the fund, we may highlight Moneyfarm, ENTEROME Bioscience, ALTILIA. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Italy.

The increased amount of exits for fund were in 2017. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. When the investment is from Principia SGR the average startup value is 5-10 millions dollars. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2012. Comparing to the other companies, this Principia SGR performs on 23 percentage points less the average number of lead investments.

The current fund was established by Pierluigi Paracchi. Besides them, we counted 8 critical employees of this fund in our database.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
52
Lead investments
18
Exits
5
Rounds per year
2.48
Follow on index
0.19
Investments by industry
  • Health Care (13)
  • Biotechnology (12)
  • Software (11)
  • Biopharma (5)
  • Life Science (5)
  • Show 75 more
Investments by region
  • France (4)
  • Italy (37)
  • United Kingdom (4)
  • United States (3)
  • Canada (2)
  • Show 1 more
Peak activity year
2012

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
575K
Group Appearance index
0.50
Avg. company exit year
10
Avg. multiplicator
0.74

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Applix 15 Oct 2011 Mobile, Enterprise Software, iOS Early Stage Venture 3M Italy, Sardinia, Cagliari
Moneyfarm 01 Aug 2012 Financial Services, FinTech, Advice, Wealth Management Seed 3M England, London, United Kingdom
Smart Greenhouse Control Kft. 14 Dec 2021 Seed 825K
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.